Pair Name | Propyl gallate, Cisplatin | ||
Phytochemical Name | Propyl gallate (PubChem CID: 4947 ) | ||
Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Propyl gallate, Cisplatin | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Target-->HO-1 | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Expression | CYCS | hsa54205 | |
Down-regulation | Expression | HMOX1 | hsa3162 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Down-regulation | Expression | RNF139 | hsa11236 | |
In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
Result | Our data provide the potential application of PG in combination chemotherapy to enhance drug sensitivity in lung cancer by targeting HO-1. |
No. | Title | Href |
---|---|---|
1 | Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation. Eur J Pharmacol. 2016 Oct 5;788:321-327. doi: 10.1016/j.ejphar.2016.06.052. | Click |